{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase ABL inhibitor","chemblIds":["CHEMBL1908397"],"targetName":"Tyrosine-protein kinase ABL","targetType":"single protein","targets":["ENSG00000097007"],"references":[{"source":"PubMed","ids":["19541823","21474579","19541823","21474579","19541823","21474579","19541823","21474579"],"urls":["http://europepmc.org/abstract/MED/19541823","http://europepmc.org/abstract/MED/21474579","http://europepmc.org/abstract/MED/19541823","http://europepmc.org/abstract/MED/21474579","http://europepmc.org/abstract/MED/19541823","http://europepmc.org/abstract/MED/21474579","http://europepmc.org/abstract/MED/19541823","http://europepmc.org/abstract/MED/21474579"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Opioid receptors; mu/kappa/delta agonist","chemblIds":["CHEMBL2364605"],"targetName":"Opioid receptors; mu/kappa/delta","targetType":"protein family","targets":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"references":[{"source":"PubMed","ids":["24713140","25147603","24713140","25147603"],"urls":["http://europepmc.org/abstract/MED/24713140","http://europepmc.org/abstract/MED/25147603","http://europepmc.org/abstract/MED/24713140","http://europepmc.org/abstract/MED/25147603"]},{"source":"Wikipedia","ids":["多-opioid_receptor","多-opioid_receptor"],"urls":["http://en.wikipedia.org/wiki/多-opioid_receptor","http://en.wikipedia.org/wiki/多-opioid_receptor"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase JAK2 inhibitor","chemblIds":["CHEMBL1795071","CHEMBL1789941"],"targetName":"Tyrosine-protein kinase JAK2","targetType":"single protein","targets":["ENSG00000096968"],"references":[{"source":"FDA","ids":["label/2012/202192s001lbl.pdf","label/2012/202192s001lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202192s001lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202192s001lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Insulin receptor inhibitor","chemblIds":["CHEMBL575448"],"targetName":"Insulin receptor","targetType":"single protein","targets":["ENSG00000171105"],"references":[{"source":"PubMed","ids":["19996272","21875414","19996272","21875414"],"urls":["http://europepmc.org/abstract/MED/19996272","http://europepmc.org/abstract/MED/21875414","http://europepmc.org/abstract/MED/19996272","http://europepmc.org/abstract/MED/21875414"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Ileal bile acid transporter inhibitor","chemblIds":["CHEMBL17879","CHEMBL363392"],"targetName":"Ileal bile acid transporter","targetType":"single protein","targets":["ENSG00000125255"],"references":[{"source":"FDA","ids":["label/2021/214662s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214662s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial DNA gyrase inhibitor","chemblIds":["CHEMBL3989504","CHEMBL108821"],"targetName":"Bacterial DNA gyrase","targetType":"protein complex","targets":[],"references":[{"source":"PubMed","ids":["18390884","18390884"],"urls":["http://europepmc.org/abstract/MED/18390884","http://europepmc.org/abstract/MED/18390884"]},{"source":"Other","ids":["https://journals.sagepub.com/doi/full/10.4137/CMT.S7435","https://journals.sagepub.com/doi/full/10.4137/CMT.S7435"],"urls":["https://journals.sagepub.com/doi/full/10.4137/CMT.S7435","https://journals.sagepub.com/doi/full/10.4137/CMT.S7435"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase ABL inhibitor","chemblIds":["CHEMBL1946170"],"targetName":"Tyrosine-protein kinase ABL","targetType":"single protein","targets":["ENSG00000097007"],"references":[{"source":"Expert","ids":["REGORAFENIB","REGORAFENIB","REGORAFENIB","REGORAFENIB","REGORAFENIB","REGORAFENIB","REGORAFENIB","REGORAFENIB","REGORAFENIB","REGORAFENIB","REGORAFENIB","REGORAFENIB","REGORAFENIB"],"urls":["http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB","http://chembl.blogspot.co.uk/search?q=REGORAFENIB"]},{"source":"FDA","ids":["label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf","label/2012/203085lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Voltage-gated calcium channel modulator","chemblIds":["CHEMBL1628502"],"targetName":"Voltage-gated calcium channel","targetType":"protein complex group","targets":["ENSG00000196557","ENSG00000153956","ENSG00000151067","ENSG00000157445","ENSG00000081248","ENSG00000007402","ENSG00000157388","ENSG00000141837","ENSG00000148408","ENSG00000006283","ENSG00000151062","ENSG00000100346","ENSG00000102001","ENSG00000198216","ENSG00000182389","ENSG00000165995","ENSG00000067191","ENSG00000167535","ENSG00000105605","ENSG00000075429","ENSG00000166862","ENSG00000075461","ENSG00000142408","ENSG00000006116","ENSG00000130433","ENSG00000108878"],"references":[{"source":"PubMed","ids":["18299583"],"urls":["http://europepmc.org/abstract/MED/18299583"]},{"source":"FDA","ids":["label/2013/022399s008lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","chemblIds":["CHEMBL101253"],"targetName":"Vascular endothelial growth factor receptor","targetType":"protein family","targets":["ENSG00000102755","ENSG00000037280","ENSG00000128052"],"references":[{"source":"PubMed","ids":["10786682","16882767","10786682","16882767","10786682","16882767","10786682","16882767"],"urls":["http://europepmc.org/abstract/MED/10786682","http://europepmc.org/abstract/MED/16882767","http://europepmc.org/abstract/MED/10786682","http://europepmc.org/abstract/MED/16882767","http://europepmc.org/abstract/MED/10786682","http://europepmc.org/abstract/MED/16882767","http://europepmc.org/abstract/MED/10786682","http://europepmc.org/abstract/MED/16882767"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Xanthine dehydrogenase inhibitor","chemblIds":["CHEMBL1078685"],"targetName":"Xanthine dehydrogenase","targetType":"single protein","targets":["ENSG00000158125"],"references":[{"source":"Other","ids":["https://www.pmda.go.jp/files/000153624.pdf"],"urls":["https://www.pmda.go.jp/files/000153624.pdf"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Insulin receptor agonist","chemblIds":["CHEMBL1201653"],"targetName":"Insulin receptor","targetType":"single protein","targets":["ENSG00000171105"],"references":[{"source":"FDA","ids":["label/2015/022472s006s008lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Adenosine A1 receptor agonist","chemblIds":["CHEMBL3545405"],"targetName":"Adenosine A1 receptor","targetType":"single protein","targets":["ENSG00000163485"],"references":[{"source":"Other","ids":["https://clinicaltrials.gov/ct2/show/NCT02040233"],"urls":["https://clinicaltrials.gov/ct2/show/NCT02040233"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor","chemblIds":["CHEMBL1456"],"targetName":"Inosine-5'-monophosphate dehydrogenase (IMPDH)","targetType":"protein family","targets":["ENSG00000106348","ENSG00000178035"],"references":[{"source":"PubMed","ids":["15621150","17463174","17713475"],"urls":["http://europepmc.org/abstract/MED/15621150","http://europepmc.org/abstract/MED/17463174","http://europepmc.org/abstract/MED/17713475"]},{"source":"DailyMed","ids":["setid=37241e87-4af4-4dc3-a1aa-ea6f20d8dc40"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=37241e87-4af4-4dc3-a1aa-ea6f20d8dc40"]}]}
{"mechanismOfAction":"Radiotherapy agent","chemblIds":["CHEMBL2107816","CHEMBL2111187"],"references":[{"source":"DailyMed","ids":["setid=a398400e-bd31-41a9-9696-4f7c06569ede#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a398400e-bd31-41a9-9696-4f7c06569ede#nlm34090-1"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL1474889"],"references":[{"source":"PubMed","ids":["19034038"],"urls":["http://europepmc.org/abstract/MED/19034038"]}]}
{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"Glycosaminoglycans hydrolytic enzyme","chemblIds":["CHEMBL3707382"],"references":[{"source":"FDA","ids":["label/2017/761047s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761047s000lbl.pdf"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Metabotropic glutamate receptor 2 agonist","chemblIds":["CHEMBL3544939"],"targetName":"Metabotropic glutamate receptor 2","targetType":"single protein","targets":["ENSG00000164082"],"references":[{"source":"Other","ids":["http://www.medchemexpress.com/DataSheet/LY2979165.html"],"urls":["http://www.medchemexpress.com/DataSheet/LY2979165.html"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Adrenergic receptor agonist","chemblIds":["CHEMBL679"],"targetName":"Adrenergic receptor","targetType":"protein family","targets":["ENSG00000120907","ENSG00000150594","ENSG00000043591","ENSG00000169252","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000274286","ENSG00000188778"],"references":[{"source":"DailyMed","ids":["setid=0d895e4c-ec4d-47ff-b624-0df457e7bfc7"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d895e4c-ec4d-47ff-b624-0df457e7bfc7"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","chemblIds":["CHEMBL3545320"],"targetName":"Mitochondrial complex I (NADH dehydrogenase)","targetType":"protein complex","targets":["ENSG00000198695","ENSG00000130414","ENSG00000110717","ENSG00000212907","ENSG00000184983","ENSG00000198888","ENSG00000165264","ENSG00000189043","ENSG00000174886","ENSG00000099795","ENSG00000198763","ENSG00000158864","ENSG00000198786","ENSG00000119421","ENSG00000136521","ENSG00000198886","ENSG00000198840","ENSG00000004779","ENSG00000125356","ENSG00000164258","ENSG00000119013","ENSG00000109390","ENSG00000131495","ENSG00000168653","ENSG00000115286","ENSG00000145494","ENSG00000183648","ENSG00000213619","ENSG00000170906","ENSG00000065518","ENSG00000166136","ENSG00000090266","ENSG00000267855","ENSG00000151366","ENSG00000140990","ENSG00000178127","ENSG00000023228","ENSG00000167792","ENSG00000160194","ENSG00000128609","ENSG00000139180","ENSG00000164182","ENSG00000178057","ENSG00000185633","ENSG00000147123","ENSG00000123545","ENSG00000186010","ENSG00000184752","ENSG00000137806","ENSG00000147684"],"references":[{"source":"Other","ids":["http://www.meipharma.com/our-programs/me-344"],"urls":["http://www.meipharma.com/our-programs/me-344"]},{"source":"PubMed","ids":["25411085","25973307"],"urls":["http://europepmc.org/abstract/MED/25411085","http://europepmc.org/abstract/MED/25973307"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Phosphodiesterase 10A inhibitor","chemblIds":["CHEMBL3545271"],"targetName":"Phosphodiesterase 10A","targetType":"single protein","targets":["ENSG00000112541"],"references":[{"source":"Other","ids":["http://www.palobiofarma.com","http://www.palobiofarma.com"],"urls":["http://www.palobiofarma.com","http://www.palobiofarma.com"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase receptor UFO inhibitor","chemblIds":["CHEMBL3809489"],"targetName":"Tyrosine-protein kinase receptor UFO","targetType":"single protein","targets":["ENSG00000167601"],"references":[{"source":"PubMed","ids":["20145120"],"urls":["http://europepmc.org/abstract/MED/20145120"]},{"source":"Other","ids":["http://www.bergenbio.com/pipeline/"],"urls":["http://www.bergenbio.com/pipeline/"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Adrenergic receptor alpha agonist","chemblIds":["CHEMBL1200413","CHEMBL1266"],"targetName":"Adrenergic receptor alpha","targetType":"protein family","targets":["ENSG00000120907","ENSG00000150594","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000274286"],"references":[{"source":"PubMed","ids":["18259967"],"urls":["http://europepmc.org/abstract/MED/18259967"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Human immunodeficiency virus type 1 integrase inhibitor","chemblIds":["CHEMBL1256978"],"targetName":"Human immunodeficiency virus type 1 integrase","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["18160521","19178153"],"urls":["http://europepmc.org/abstract/MED/18160521","http://europepmc.org/abstract/MED/19178153"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"C-C chemokine receptor type 5 antagonist","chemblIds":["CHEMBL1951914"],"targetName":"C-C chemokine receptor type 5","targetType":"single protein","targets":["ENSG00000160791"],"references":[{"source":"PubMed","ids":["20662070","22266038"],"urls":["http://europepmc.org/abstract/MED/20662070","http://europepmc.org/abstract/MED/22266038"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Beta-2 adrenergic receptor agonist","chemblIds":["CHEMBL1201061","CHEMBL1002"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[{"source":"PubMed","ids":["22144765"],"urls":["http://europepmc.org/abstract/MED/22144765"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Prostanoid FP receptor agonist","chemblIds":["CHEMBL2364612"],"targetName":"Prostanoid FP receptor","targetType":"single protein","targets":["ENSG00000122420"],"references":[{"source":"Other","ids":["http://www.nicox.com/rd/ophthalmic-pipeline/vesneo-latanoprostene-bunod-2/"],"urls":["http://www.nicox.com/rd/ophthalmic-pipeline/vesneo-latanoprostene-bunod-2/"]},{"source":"PubMed","ids":["21396362","25488946"],"urls":["http://europepmc.org/abstract/MED/21396362","http://europepmc.org/abstract/MED/25488946"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Estrogen receptor modulator","chemblIds":["CHEMBL2106615","CHEMBL46740"],"targetName":"Estrogen receptor","targetType":"protein family","targets":["ENSG00000140009","ENSG00000091831"],"references":[{"source":"FDA","ids":["label/2013/022247Orig1s001lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022247Orig1s001lbl.pdf"]},{"source":"PubMed","ids":["24373794"],"urls":["http://europepmc.org/abstract/MED/24373794"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial penicillin-binding protein inhibitor","chemblIds":["CHEMBL1604"],"targetName":"Bacterial penicillin-binding protein","targetType":"protein family","targets":[],"references":[{"source":"PubMed","ids":["7592463"],"urls":["http://europepmc.org/abstract/MED/7592463"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatocyte growth factor receptor inhibitor","chemblIds":["CHEMBL2133806"],"targetName":"Hepatocyte growth factor receptor","targetType":"single protein","targets":["ENSG00000105976"],"references":[{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/68/9_Supplement/4837"],"urls":["http://cancerres.aacrjournals.org/content/68/9_Supplement/4837"]},{"source":"PubMed","ids":["19318488"],"urls":["http://europepmc.org/abstract/MED/19318488"]}]}
{"actionType":"POSITIVE MODULATOR","mechanismOfAction":"Dystrophin pre-mRNA positive modulator","chemblIds":["CHEMBL4298192"],"targetName":"Dystrophin pre-mRNA","targetType":"nucleic-acid","targets":["ENSG00000198947"],"references":[{"source":"Other","ids":["https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-discontinuation-suvodirsen","https://www.nmd-journal.com/article/S0960-8966(19)30699-6/fulltext"],"urls":["https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-discontinuation-suvodirsen","https://www.nmd-journal.com/article/S0960-8966(19)30699-6/fulltext"]},{"source":"ClinicalTrials","ids":["NCT03907072"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT03907072"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Synaptosomal-associated protein 25 inhibitor","chemblIds":["CHEMBL2108035"],"targetName":"Synaptosomal nerve-associated protein 25 (SNAP-25)","targetType":"single protein","targets":["ENSG00000132639"],"references":[{"source":"FDA","ids":["label/2013/125360s045lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125360s045lbl.pdf"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Progesterone receptor modulator","chemblIds":["CHEMBL267431"],"targetName":"Progesterone receptor","targetType":"single protein","targets":["ENSG00000082175"],"references":[{"source":"PubMed","ids":["14667995","15714390"],"urls":["http://europepmc.org/abstract/MED/14667995","http://europepmc.org/abstract/MED/15714390"]},{"source":"Wikipedia","ids":["Asoprisnil"],"urls":["http://en.wikipedia.org/wiki/Asoprisnil"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Phosphodiesterase 3 inhibitor","chemblIds":["CHEMBL190"],"targetName":"Phosphodiesterase 3","targetType":"protein family","targets":["ENSG00000172572","ENSG00000152270"],"references":[{"source":"PubMed","ids":["12954362","14992338","15980878","3588607"],"urls":["http://europepmc.org/abstract/MED/12954362","http://europepmc.org/abstract/MED/14992338","http://europepmc.org/abstract/MED/15980878","http://europepmc.org/abstract/MED/3588607"]},{"source":"Wikipedia","ids":["Theophylline#Mechanisms_of_action","Theophylline#Mechanisms_of_action","Theophylline#Mechanisms_of_action"],"urls":["http://en.wikipedia.org/wiki/Theophylline#Mechanisms_of_action","http://en.wikipedia.org/wiki/Theophylline#Mechanisms_of_action","http://en.wikipedia.org/wiki/Theophylline#Mechanisms_of_action"]},{"source":"DailyMed","ids":["setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8","setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8"]}]}
{"actionType":"CROSS-LINKING AGENT","mechanismOfAction":"T cell surface glycoprotein CD3 cross-linking agent","chemblIds":["CHEMBL2109264"],"targetName":"T cell surface glycoprotein CD3","targetType":"protein complex","targets":["ENSG00000198851","ENSG00000160654","ENSG00000167286"],"references":[{"source":"PubMed","ids":["26272866","26272866"],"urls":["http://europepmc.org/abstract/MED/26272866","http://europepmc.org/abstract/MED/26272866"]}]}
{"actionType":"AGONIST","mechanismOfAction":"LXR-beta agonist","chemblIds":["CHEMBL3545418"],"targetName":"LXR-beta","targetType":"single protein","targets":["ENSG00000131408"],"references":[{"source":"PubMed","ids":["24833295","25467132"],"urls":["http://europepmc.org/abstract/MED/24833295","http://europepmc.org/abstract/MED/25467132"]},{"source":"Other","ids":["http://www.exelixis.com/pipeline/xl652"],"urls":["http://www.exelixis.com/pipeline/xl652"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","chemblIds":["CHEMBL522892"],"targetName":"Vascular endothelial growth factor receptor","targetType":"protein family","targets":["ENSG00000102755","ENSG00000037280","ENSG00000128052"],"references":[{"source":"PubMed","ids":["15897558","15897558","15897558","15897558","15897558"],"urls":["http://europepmc.org/abstract/MED/15897558","http://europepmc.org/abstract/MED/15897558","http://europepmc.org/abstract/MED/15897558","http://europepmc.org/abstract/MED/15897558","http://europepmc.org/abstract/MED/15897558"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Mu opioid receptor antagonist","chemblIds":["CHEMBL270190"],"targetName":"Mu opioid receptor","targetType":"single protein","targets":["ENSG00000112038"],"references":[{"source":"FDA","ids":["label/2013/021775s010lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021775s010lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial 70S ribosome inhibitor","chemblIds":["CHEMBL1607480","CHEMBL1517"],"targetName":"Bacterial 70S ribosome","targetType":"protein nucleic-acid complex","targets":[],"references":[{"source":"KEGG","ids":["D01596"],"urls":["http://www.kegg.jp/dbget-bin/www_bget?dr:D01596"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Phosphodiesterase 9A inhibitor","chemblIds":["CHEMBL4297290"],"targetName":"Phosphodiesterase 9A","targetType":"single protein","targets":["ENSG00000160191"],"references":[{"source":"Other","ids":["https://imaratx.com/our-programs/"],"urls":["https://imaratx.com/our-programs/"]},{"source":"PubMed","ids":["31147439"],"urls":["http://europepmc.org/abstract/MED/31147439"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Muscarinic acetylcholine receptor M3 antagonist","chemblIds":["CHEMBL1200479","CHEMBL1123"],"targetName":"Muscarinic acetylcholine receptor M3","targetType":"single protein","targets":["ENSG00000133019"],"references":[{"source":"ISBN","ids":["9780702034718 PP. 153","9780702034718 PP. 153"],"urls":["http://www.isbnsearch.org/isbn/9780702034718","http://www.isbnsearch.org/isbn/9780702034718"]},{"source":"DailyMed","ids":["setid=c56598d5-9cd1-4cce-b172-ac338775aec7","setid=c56598d5-9cd1-4cce-b172-ac338775aec7"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c56598d5-9cd1-4cce-b172-ac338775aec7","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c56598d5-9cd1-4cce-b172-ac338775aec7"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor","chemblIds":["CHEMBL849"],"targetName":"Bacterial enoyl-[acyl-carrier-protein] reductase","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["10196195"],"urls":["http://europepmc.org/abstract/MED/10196195"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tubulin inhibitor","chemblIds":["CHEMBL1743037"],"targetName":"Tubulin","targetType":"protein complex group","targets":["ENSG00000188229","ENSG00000101162","ENSG00000198033","ENSG00000127824","ENSG00000258947","ENSG00000167552","ENSG00000104833","ENSG00000261456","ENSG00000196230","ENSG00000123416","ENSG00000167553","ENSG00000152086","ENSG00000137267","ENSG00000137285","ENSG00000176014"],"references":[{"source":"PubMed","ids":["24492307"],"urls":["http://europepmc.org/abstract/MED/24492307"]},{"source":"Other","ids":["https://clincancerres.aacrjournals.org/content/10/13/4363"],"urls":["https://clincancerres.aacrjournals.org/content/10/13/4363"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Thymidylate synthase inhibitor","chemblIds":["CHEMBL1130"],"targetName":"Thymidylate synthase","targetType":"single protein","targets":["ENSG00000176890"],"references":[{"source":"PubMed","ids":["23564503","23564503","23564503"],"urls":["http://europepmc.org/abstract/MED/23564503","http://europepmc.org/abstract/MED/23564503","http://europepmc.org/abstract/MED/23564503"]},{"source":"FDA","ids":["label/2016/012209s040lbl.pdf","label/2016/012209s040lbl.pdf","label/2016/012209s040lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012209s040lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012209s040lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012209s040lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Sclerostin inhibitor","chemblIds":["CHEMBL2107874"],"targetName":"Sclerostin","targetType":"single protein","targets":["ENSG00000167941"],"references":[{"source":"PubMed","ids":["22031665"],"urls":["http://europepmc.org/abstract/MED/22031665"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Sodium channel alpha subunit blocker","chemblIds":["CHEMBL919","CHEMBL1201336"],"targetName":"Sodium channel alpha subunit","targetType":"protein family","targets":["ENSG00000144285","ENSG00000183873","ENSG00000007314","ENSG00000136546","ENSG00000136531","ENSG00000169432","ENSG00000153253","ENSG00000168356","ENSG00000196876","ENSG00000185313"],"references":[{"source":"PubMed","ids":["15208697","23205958"],"urls":["http://europepmc.org/abstract/MED/15208697","http://europepmc.org/abstract/MED/23205958"]},{"source":"DailyMed","ids":["setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Programmed cell death protein 1 inhibitor","chemblIds":["CHEMBL4297840"],"targetName":"Programmed cell death protein 1","targetType":"single protein","targets":["ENSG00000188389"],"references":[{"source":"PubMed","ids":["33044117"],"urls":["http://europepmc.org/abstract/MED/33044117"]},{"source":"Other","ids":["https://ir.beigene.com/news-releases/news-release-details/beigene-announces-phase-3-trial-tislelizumab-combined","https://www.novartis.com/news/media-releases/novartis-strengthens-oncology-pipeline-successful-closing-tislelizumab-licensing"],"urls":["https://ir.beigene.com/news-releases/news-release-details/beigene-announces-phase-3-trial-tislelizumab-combined","https://www.novartis.com/news/media-releases/novartis-strengthens-oncology-pipeline-successful-closing-tislelizumab-licensing"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Glucocorticoid receptor agonist","chemblIds":["CHEMBL2105842"],"targetName":"Glucocorticoid receptor","targetType":"single protein","targets":["ENSG00000113580"],"references":[{"source":"PubMed","ids":["11741935","16158972","17606285","2039752","2702665","4029081","7564524","8419910"],"urls":["http://europepmc.org/abstract/MED/11741935","http://europepmc.org/abstract/MED/16158972","http://europepmc.org/abstract/MED/17606285","http://europepmc.org/abstract/MED/2039752","http://europepmc.org/abstract/MED/2702665","http://europepmc.org/abstract/MED/4029081","http://europepmc.org/abstract/MED/7564524","http://europepmc.org/abstract/MED/8419910"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Spike glycoprotein inhibitor","chemblIds":["CHEMBL4650524"],"targetName":"Spike glycoprotein","targetType":"single protein","targets":[],"references":[{"source":"EMA","ids":["https://www.ema.europa.eu/en/documents/referral/sotrovimab-also-known-vir-7831-gsk4182136-covid19-article-53-procedure-conditions-use-conditions_en.pdf"],"urls":["https://www.ema.europa.eu/en/documents/referral/sotrovimab-also-known-vir-7831-gsk4182136-covid19-article-53-procedure-conditions-use-conditions_en.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Programmed cell death 1 ligand 1 inhibitor","chemblIds":["CHEMBL3301587"],"targetName":"Programmed cell death 1 ligand 1","targetType":"single protein","targets":["ENSG00000120217"],"references":[{"source":"PubMed","ids":["25943534","27265743"],"urls":["http://europepmc.org/abstract/MED/25943534","http://europepmc.org/abstract/MED/27265743"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor","chemblIds":["CHEMBL550936"],"targetName":"Hepatitis C virus NS5B RNA-dependent RNA polymerase","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["22807519"],"urls":["http://europepmc.org/abstract/MED/22807519"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","chemblIds":["CHEMBL377300"],"targetName":"Vascular endothelial growth factor receptor","targetType":"protein family","targets":["ENSG00000102755","ENSG00000037280","ENSG00000128052"],"references":[{"source":"PubMed","ids":["18288793","18829493","18288793","18829493"],"urls":["http://europepmc.org/abstract/MED/18288793","http://europepmc.org/abstract/MED/18829493","http://europepmc.org/abstract/MED/18288793","http://europepmc.org/abstract/MED/18829493"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Eotaxin inhibitor","chemblIds":["CHEMBL2109103"],"targetName":"Eotaxin","targetType":"single protein","targets":["ENSG00000172156"],"references":[{"source":"PubMed","ids":["16973884"],"urls":["http://europepmc.org/abstract/MED/16973884"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"80S Ribosome inhibitor","chemblIds":["CHEMBL4297789"],"targetName":"80S Ribosome","targetType":"protein nucleic-acid complex","targets":["ENSG00000168028","ENSG00000177954","ENSG00000137154","ENSG00000140988","ENSG00000149273","ENSG00000145425","ENSG00000198034","ENSG00000129824","ENSG00000083845","ENSG00000171863","ENSG00000142937","ENSG00000170889","ENSG00000124614","ENSG00000142534","ENSG00000112306","ENSG00000110700","ENSG00000164587","ENSG00000115268","ENSG00000134419","ENSG00000105193","ENSG00000182774","ENSG00000231500","ENSG00000105372","ENSG00000008988","ENSG00000171858","ENSG00000186468","ENSG00000138326","ENSG00000118181","ENSG00000197728","ENSG00000143947","ENSG00000233927","ENSG00000213741","ENSG00000149806","ENSG00000100316","ENSG00000174444","ENSG00000122406","ENSG00000089009","ENSG00000147604","ENSG00000148303","ENSG00000161016","ENSG00000163682","ENSG00000147403","ENSG00000198755","ENSG00000142676","ENSG00000197958","ENSG00000167526","ENSG00000142541","ENSG00000188846","ENSG00000174748","ENSG00000265681","ENSG00000063177","ENSG00000105640","ENSG00000108298","ENSG00000122026","ENSG00000116251","ENSG00000125691","ENSG00000198242","ENSG00000114391","ENSG00000161970","ENSG00000131469","ENSG00000166441","ENSG00000108107","ENSG00000162244","ENSG00000156482","ENSG00000071082","ENSG00000144713","ENSG00000109475","ENSG00000136942","ENSG00000182899","ENSG00000130255","ENSG00000241343","ENSG00000145592","ENSG00000197756","ENSG00000172809","ENSG00000198918","ENSG00000229117","ENSG00000089157","ENSG00000137818"],"references":[{"source":"PubMed","ids":["31847708","31847708"],"urls":["http://europepmc.org/abstract/MED/31847708","http://europepmc.org/abstract/MED/31847708"]},{"source":"Other","ids":["https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.TPS8074","https://onlinelibrary.wiley.com/doi/full/10.1002/hon.13_2632","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.TPS8074","https://onlinelibrary.wiley.com/doi/full/10.1002/hon.13_2632"],"urls":["https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.TPS8074","https://onlinelibrary.wiley.com/doi/full/10.1002/hon.13_2632","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.TPS8074","https://onlinelibrary.wiley.com/doi/full/10.1002/hon.13_2632"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA gyrase inhibitor","chemblIds":["CHEMBL31"],"targetName":"DNA gyrase","targetType":"protein complex","targets":[],"references":[{"source":"FDA","ids":["label/2015/021493s010lbl.pdf","label/2015/021493s010lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021493s010lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021493s010lbl.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Glutamate NMDA receptor; GRIN1/GRIN2B antagonist","chemblIds":["CHEMBL17350"],"targetName":"Glutamate NMDA receptor; GRIN1/GRIN2B","targetType":"protein complex","targets":["ENSG00000176884","ENSG00000273079"],"references":[{"source":"DOI","ids":["10.1111/j.1527-3458.1998.tb00073.x"],"urls":["http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.1998.tb00073.x/abstract;jsessionid=BB969FABCAB6BFF549E3C10621012C0A.f01t01"]},{"source":"PubMed","ids":["11897110","21699507"],"urls":["http://europepmc.org/abstract/MED/11897110","http://europepmc.org/abstract/MED/21699507"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Oxytocin receptor agonist","chemblIds":["CHEMBL3545167"],"targetName":"Oxytocin receptor","targetType":"single protein","targets":["ENSG00000180914"],"references":[{"source":"PubMed","ids":["24874785"],"urls":["http://europepmc.org/abstract/MED/24874785"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tumor necrosis factor receptor superfamily member 5 inhibitor","chemblIds":["CHEMBL2109475"],"targetName":"Tumor necrosis factor receptor superfamily member 5","targetType":"single protein","targets":["ENSG00000101017"],"references":[{"source":"PubMed","ids":["25795759"],"urls":["http://europepmc.org/abstract/MED/25795759"]}]}
{"actionType":"RNAI INHIBITOR","mechanismOfAction":"Hydroxyacid oxidase 1 mRNA RNAi inhibitor","chemblIds":["CHEMBL4297779"],"targetName":"Hydroxyacid oxidase 1 mRNA","targetType":"nucleic-acid","targets":["ENSG00000101323"],"references":[{"source":"FDA","ids":["label/2020/214103lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214103lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase B-raf inhibitor","chemblIds":["CHEMBL3301612"],"targetName":"Serine/threonine-protein kinase B-raf","targetType":"single protein","targets":["ENSG00000157764"],"references":[{"source":"PubMed","ids":["23617957"],"urls":["http://europepmc.org/abstract/MED/23617957"]},{"source":"DOI","ids":["10.1158/1538-7445.AM2012-3790"],"urls":["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790"]}]}
{"actionType":"RELEASING AGENT","mechanismOfAction":"Dopamine transporter releasing agent","chemblIds":["CHEMBL1200377","CHEMBL405"],"targetName":"Dopamine transporter","targetType":"single protein","targets":["ENSG00000142319"],"references":[{"source":"PubMed","ids":["15602501","15795321"],"urls":["http://europepmc.org/abstract/MED/15602501","http://europepmc.org/abstract/MED/15795321"]},{"source":"KEGG","ids":["D07445","D07445"],"urls":["http://www.kegg.jp/dbget-bin/www_bget?dr:D07445","http://www.kegg.jp/dbget-bin/www_bget?dr:D07445"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Beta-2 adrenergic receptor agonist","chemblIds":["CHEMBL2105743","CHEMBL605846"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[{"source":"FDA","ids":["label/2014/203108s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203108s000lbl.pdf"]}]}
{"actionType":"DISRUPTING AGENT","mechanismOfAction":"Cell membrane disrupting agent","chemblIds":["CHEMBL4297712"],"references":[{"source":"PubMed","ids":["21518845"],"urls":["https://pubmed.ncbi.nlm.nih.gov/21518845/"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Serotonin 2a (5-HT2a) receptor antagonist","chemblIds":["CHEMBL2107360"],"targetName":"Serotonin 2a (5-HT2a) receptor","targetType":"single protein","targets":["ENSG00000102468"],"references":[{"source":"FDA","ids":["label/2011/022264s006lbl.pdf","label/2011/022264s006lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022264s006lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022264s006lbl.pdf"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Prostanoid FP receptor agonist","chemblIds":["CHEMBL1051"],"targetName":"Prostanoid FP receptor","targetType":"single protein","targets":["ENSG00000122420"],"references":[{"source":"FDA","ids":["label/2014/020597s045s048lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020597s045s048lbl.pdf"]}]}
